| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-09 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-08 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
7e-08 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-07 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-07 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
9e-07 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-06 |